Association study of hypoxia inducible factor 1α (HIF1α) with osteonecrosis of femoral head in a Korean population

Osteoarthritis and Cartilage

Volumn 15, Issue 6, 2007, Pages 688-694

  Hong, J Min ^a   Kim, T H ^a,b   Chae, S C ^c   Koo, K H ^d   Lee, Y Jong ^d   Park, E Kyun ^a,e   Choi, J Y ^a,b   Ryoo, H M ^a,f   Kim, S Y ^a  

^a Kyungpook National University Hospital   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Wonkwang University School of Medicine   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

^e Kyungpook National University   (South Korea)

^f School of Dentistry   (South Korea)

Author keywords

Femoral head; HIF1 ; Hypoxia; Osteonecrosis; Polymorphism; SNP

Indexed keywords

ALCOHOL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PREDNISOLONE; STEROID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FEMUR HEAD NECROSIS; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; IDIOPATHIC DISEASE; KOREA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FEMUR; FEMUR HEAD NECROSIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KOREA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 34249002087     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2006.12.007     Document Type: Article

References (37)

1. Assouline-Dayan Y., Chang C., Greenspan A., Shoenfeld Y., and Gershwin M.E. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 32 (2002) 94-124
2. Boss J.H., Misselevich I., Bejar J., Norman D., Zinman C., and Reis D.N. Experimentally gained insight-based proposal apropos the treatment of osteonecrosis of the femoral head. Med Hypotheses 62 (2004) 958-965
3. Mont M.A., Jones L.C., Einhorn T.A., Hungerford D.S., and Reddi A.H. Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors. Clin Orthop (1998) S314-S315
4. Childs S.G. Osteonecrosis: death of bone cells. Orthop Nurs 24 (2005) 295-301 quiz 302-3
5. Ryan H.E., Lo J., and Johnson R.S. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. Embo J 17 (1998) 3005-3015
6. Semenza G.L. HIF-1 and human disease: one highly involved factor. Genes Dev 14 (2000) 1983-1991
7. Semenza G.L. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 13 (2001) 167-171
8. Jiang B.H., Semenza G.L., Bauer C., and Marti H.H. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol 271 (1996) C1172-C1180
9. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399 (1999) 271-275
10. Marxsen J.H., Stengel P., Doege K., Heikkinen P., Jokilehto T., Wagner T., et al. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochem J 381 (2004) 761-767
11. Lin C., McGough R., Aswad B., Block J.A., and Terek R. Hypoxia induces HIF-1alpha and VEGF expression in chondrosarcoma cells and chondrocytes. J Orthop Res 22 (2004) 1175-1181
12. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394 (1998) 485-490
13. Ferrari P., Schroeder V., Anderson S., Kocovic L., Vogt B., Schiesser D., et al. Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients. Transplantation 74 (2002) 1147-1152
14. Radke S., Battmann A., Jatzke S., Eulert J., Jakob F., and Schutze N. Expression of the angiomatrix and angiogenic proteins CYR61, CTGF, and VEGF in osteonecrosis of the femoral head. J Orthop Res 24 (2006) 945-952
15. Miyanishi K., Kamo Y., Ihara H., Naka T., Hirakawa M., and Sugioka Y. Risk Factors for Dysbaric Osteonecrosis (2006), Rheumatology, Oxford
16. Zalavras C.G., Malizos K.N., Dokou E., and Vartholomatos G. The 677C→T mutation of the methylene-tetrahydrofolate reductase gene in the pathogenesis of osteonecrosis of the femoral head. Haematologica 87 (2002) 111-112
17. Glueck C.J., Freiberg R.A., Fontaine R.N., Tracy T., and Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop (2001) 19-33
18. Glueck C.J., Fontaine R.N., Gruppo R., Stroop D., Sieve-Smith L., Tracy T., et al. The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis. Clin Orthop (1999) 133-146
19. Schipani E., Ryan H.E., Didrickson S., Kobayashi T., Knight M., and Johnson R.S. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 15 (2001) 2865-2876
20. Komatsu D.E., and Hadjiargyrou M. Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair. Bone 34 (2004) 680-688
21. Mori S., Akagi M., Kikuyama A., Yasuda Y., and Hamanishi C. Axial shortening during distraction osteogenesis leads to enhanced bone formation in a rabbit model through the HIF-1alpha/vascular endothelial growth factor system. J Orthop Res 24 (2006) 653-663
22. Koo K.H., Kim R., Kim Y.S., Ahn I.O., Cho S.H., Song H.R., et al. Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment. Clin Rheumatol 21 (2002) 299-303
23. Matsuo K., Hirohata T., Sugioka Y., Ikeda M., and Fukuda A. Influence of alcohol intake, cigarette smoking, and occupational status on idiopathic osteonecrosis of the femoral head. Clin Orthop (1988) 115-123
24. Qin Z.S., Niu T., and Liu J.S. Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet 71 (2002) 1242-1247
25. Chen W.M., Liu Y.F., Lin M.W., Chen I.C., Lin P.Y., Lin G.L., et al. Autosomal dominant avascular necrosis of femoral head in two Taiwanese pedigrees and linkage to chromosome 12q13. Am J Hum Genet 75 (2004) 310-317
26. Semenza G.L., Roth P.H., Fang H.M., and Wang G.L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269 (1994) 23757-23763
27. Semenza G.L. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 7 (2001) 345-350
28. Ling T.S., Shi R.H., Zhang G.X., Zhu H., Yu L.Z., and Ding X.F. Common single nucleotide polymorphism of hypoxia-inducible factor-1alpha and its impact on the clinicopathological features of esophageal squamous cell carcinoma. Chin J Dig Dis 6 (2005) 155-158
29. Fu X.S., Choi E., Bubley G.J., and Balk S.P. Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. Prostate 63 (2005) 215-221
30. Ollerenshaw M., Page T., Hammonds J., and Demaine A. Polymorphisms in the hypoxia inducible factor-1alpha gene (HIF1A) are associated with the renal cell carcinoma phenotype. Cancer Genet Cytogenet 153 (2004) 122-126
31. De Armond R., Wood S., Sun D., Hurley L.H., and Ebbinghaus S.W. Evidence for the presence of a guanine quadruplex forming region within a polypurine tract of the hypoxia inducible factor 1alpha promoter. Biochemistry 44 (2005) 16341-16350
32. Van Veldhuizen P.J., Neff J., Murphey M.D., Bodensteiner D., and Skikne B.S. Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. Am J Hematol 44 (1993) 243-248
33. Hungerford D.S., and Jones L.C. Asymptomatic osteonecrosis: should it be treated?. Clin Orthop (2004) 124-130
34. Asano T., Takahashi K.A., Fujioka M., Inoue S., Satomi Y., Nishino H., et al. Genetic analysis of steroid-induced osteonecrosis of the femoral head. J Orthop Sci 8 (2003) 329-333
35. Li J., Bosch-Marce M., Nanayakkara A., Savransky V., Fried S.K., Semenza G.L., et al. Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha. Physiol Genomics 25 (2006) 450-457
36. Wada Y., Sugiyama A., Yamamoto T., Naito M., Noguchi N., Yokoyama S., et al. Lipid accumulation in smooth muscle cells under LDL loading is independent of LDL receptor pathway and enhanced by hypoxic conditions. Arterioscler Thromb Vasc Biol 22 (2002) 1712-1719
37. Bruder E.D., Lee P.C., and Raff H. Metabolomic analysis of adrenal lipids during hypoxia in the neonatal rat: implications in steroidogenesis. Am J Physiol Endocrinol Metab 286 (2004) E697-E703